These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24009274)

  • 1. Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?
    Adams HJ; Kwee TC; Nievelstein RA
    J Nucl Med; 2013 Nov; 54(11):2017-8. PubMed ID: 24009274
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?
    Berthet L; Humbert O; Cochet A
    J Nucl Med; 2013 Nov; 54(11):2018. PubMed ID: 24029654
    [No Abstract]   [Full Text] [Related]  

  • 3. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
    J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan.
    Hong J; Lee JH
    Ann Hematol; 2013 Apr; 92(4):565-6. PubMed ID: 23086509
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET/CT versus bone marrow biopsy.
    Cortés-Romera M; Sabaté-Llobera A; Mercadal-Vilchez S; Climent-Esteller F; Serrano-Maestro A; Gámez-Cenzano C; González-Barca E
    Clin Nucl Med; 2014 Jan; 39(1):e46-52. PubMed ID: 23640215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma.
    Hong J; Lee Y; Park Y; Kim SG; Hwang KH; Park SH; Jeong J; Kim KH; Ahn JY; Park S; Park J; Lee JH
    Ann Hematol; 2012 May; 91(5):687-695. PubMed ID: 22008868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a cut-off SUV level to define bone marrow lesions on FDG PET is not appropriate.
    Cheng G
    Ann Hematol; 2013 Jan; 92(2):283-4. PubMed ID: 22885991
    [No Abstract]   [Full Text] [Related]  

  • 11. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma.
    Adams HJ; Nievelstein RA; Kwee TC
    Blood Rev; 2015 Nov; 29(6):417-25. PubMed ID: 26113144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral cutaneous diffuse large B-cell lymphoma on FDG PET/CT.
    Kalender E; Yilmaz M; Erkilic S; Yilmaz M; Celen Z
    Clin Nucl Med; 2011 Oct; 36(10):e153-5. PubMed ID: 21892030
    [No Abstract]   [Full Text] [Related]  

  • 13. An unusual case of diffuse large B-cell lymphoma involving the vulva evaluated by 18F-FDG PET/CT.
    Treglia G; Paone G; Perriard U; Ceriani L; Giovanella L
    Clin Nucl Med; 2014 Oct; 39(10):e439-41. PubMed ID: 24152653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Efficacy of
    Guo B; Qin R; Gu ZY; Li YF; Gao L; Huang WR
    Biomed Environ Sci; 2023 Jun; 36(6):510-516. PubMed ID: 37424244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
    Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral bone involvement of intravascular large B-cell lymphoma on 99mTc-MDP bone scan and 18F-FDG PET/CT.
    Oh SY; Cheon GJ; Jeong E; Lee S; Park TG; Pahk K; Choe JG
    Clin Nucl Med; 2012 Aug; 37(8):810-1. PubMed ID: 22785520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging DLBCL: bone marrow biopsy or PET-CT?
    Avigdor A
    Blood; 2013 Jul; 122(1):4-5. PubMed ID: 23828884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of the role of PET imaging in diffuse large B-cell lymphoma.
    Moskowitz CH; Schöder H
    Semin Hematol; 2015 Apr; 52(2):138-42. PubMed ID: 25805593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT demonstrating primary bone lymphoma of the extremities mimicking an inflammatory peripheral arthropathy.
    Tachibana A; Robinson RJ; Patel CN
    Clin Nucl Med; 2015 Feb; 40(2):169-71. PubMed ID: 25140543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.